278 related articles for article (PubMed ID: 33326735)
1. Intermittent Hypoxia and Its Impact on Nrf2/HIF-1α Expression and ABC Transporters: An in Vitro Human Blood-Brain Barrier Model Study.
Zolotoff C; Voirin AC; Puech C; Roche F; Perek N
Cell Physiol Biochem; 2020 Dec; 54(6):1231-1248. PubMed ID: 33326735
[TBL] [Abstract][Full Text] [Related]
2. Sera of elderly obstructive sleep apnea patients alter blood-brain barrier integrity in vitro: a pilot study.
Voirin AC; Celle S; Perek N; Roche F
Sci Rep; 2020 Jul; 10(1):11309. PubMed ID: 32647186
[TBL] [Abstract][Full Text] [Related]
3. Minocycline ameliorates hypoxia-induced blood-brain barrier damage by inhibition of HIF-1α through SIRT-3/PHD-2 degradation pathway.
Yang F; Zhou L; Wang D; Wang Z; Huang QY
Neuroscience; 2015 Sep; 304():250-9. PubMed ID: 26211444
[TBL] [Abstract][Full Text] [Related]
4. Loss of Blood-Brain Barrier Integrity in an In Vitro Model Subjected to Intermittent Hypoxia: Is Reversion Possible with a HIF-1α Pathway Inhibitor?
Voirin AC; Chatard M; Briançon-Marjollet A; Pepin JL; Perek N; Roche F
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902491
[TBL] [Abstract][Full Text] [Related]
5. Assessment of HBEC-5i endothelial cell line cultivated in astrocyte conditioned medium as a human blood-brain barrier model for ABC drug transport studies.
Puech C; Hodin S; Forest V; He Z; Mismetti P; Delavenne X; Perek N
Int J Pharm; 2018 Nov; 551(1-2):281-289. PubMed ID: 30240829
[TBL] [Abstract][Full Text] [Related]
6. Nrf2 signaling increases expression of ATP-binding cassette subfamily C mRNA transcripts at the blood-brain barrier following hypoxia-reoxygenation stress.
Ibbotson K; Yell J; Ronaldson PT
Fluids Barriers CNS; 2017 Mar; 14(1):6. PubMed ID: 28298215
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia increases expression of selected blood-brain barrier transporters GLUT-1, P-gp, SLC7A5 and TFRC, while maintaining barrier integrity, in brain capillary endothelial monolayers.
Ozgür B; Helms HCC; Tornabene E; Brodin B
Fluids Barriers CNS; 2022 Jan; 19(1):1. PubMed ID: 34983574
[TBL] [Abstract][Full Text] [Related]
8. Hypercapnia Exacerbates the Blood-Brain Barrier Disruption Via Promoting HIF-1a Nuclear Translocation in the Astrocytes of the Hippocampus: Implication in Further Cognitive Impairment in Hypoxemic Adult Rats.
Liu X; Ding H; Li X; Deng Y; Liu X; Wang K; Wen M; Chen S; Jiang W; Zeng H
Neurochem Res; 2020 Jul; 45(7):1674-1689. PubMed ID: 32328929
[TBL] [Abstract][Full Text] [Related]
9. Hydralazine is a Suitable Mimetic Agent of Hypoxia to Study the Impact of Hypoxic Stress on In Vitro Blood-Brain Barrier Model.
Chatard M; Puech C; Perek N; Roche F
Cell Physiol Biochem; 2017; 42(4):1592-1602. PubMed ID: 28738383
[TBL] [Abstract][Full Text] [Related]
10. Paracellular tightness and the functional expression of efflux transporters P-gp and BCRP in bEnd3 cells.
Yang S; Jin H; Zhao Z
Neurol Res; 2018 Aug; 40(8):644-649. PubMed ID: 29683403
[TBL] [Abstract][Full Text] [Related]
11. Altered Nrf2 signaling mediates hypoglycemia-induced blood-brain barrier endothelial dysfunction in vitro.
Sajja RK; Green KN; Cucullo L
PLoS One; 2015; 10(3):e0122358. PubMed ID: 25807533
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory stress induced by a combination of cytokines (IL-6, IL-17, TNF-α) leads to a loss of integrity on bEnd.3 endothelial cells in vitro BBB model.
Voirin AC; Perek N; Roche F
Brain Res; 2020 Mar; 1730():146647. PubMed ID: 31911168
[TBL] [Abstract][Full Text] [Related]
13. Early Increase in Blood-Brain Barrier Permeability in a Murine Model Exposed to Fifteen Days of Intermittent Hypoxia.
Roche F; Briançon-Marjollet A; Dematteis M; Baldazza M; Gonthier B; Bertholon F; Perek N; Pépin JL
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474310
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression.
Yeh WL; Lu DY; Lin CJ; Liou HC; Fu WM
Mol Pharmacol; 2007 Aug; 72(2):440-9. PubMed ID: 17513385
[TBL] [Abstract][Full Text] [Related]
15. Effects of intermittent hypoxia with thrombin in an in vitro model of human brain endothelial cells and their impact on PAR-1/PAR-3 cleavage.
Zolotoff C; Puech C; Roche F; Perek N
Sci Rep; 2022 Jul; 12(1):12305. PubMed ID: 35853902
[TBL] [Abstract][Full Text] [Related]
16. Expression of ATP-binding cassette transporters at the inner blood-retinal barrier in a neonatal mouse model of oxygen-induced retinopathy.
Tagami M; Kusuhara S; Honda S; Tsukahara Y; Negi A
Brain Res; 2009 Aug; 1283():186-93. PubMed ID: 19505448
[TBL] [Abstract][Full Text] [Related]
17. Re-evaluation of the hCMEC/D3 based in vitro BBB model for ABC transporter studies.
Balzer V; Poc P; Puris E; Martin S; Aliasgari M; Auriola S; Fricker G
Eur J Pharm Biopharm; 2022 Apr; 173():12-21. PubMed ID: 35227855
[TBL] [Abstract][Full Text] [Related]
18. Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS.
Jablonski MR; Jacob DA; Campos C; Miller DS; Maragakis NJ; Pasinelli P; Trotti D
Neurobiol Dis; 2012 Aug; 47(2):194-200. PubMed ID: 22521463
[TBL] [Abstract][Full Text] [Related]
19. Hypoxic Stress Induced by Hydralazine Leads to a Loss of Blood-Brain Barrier Integrity and an Increase in Efflux Transporter Activity.
Chatard M; Puech C; Roche F; Perek N
PLoS One; 2016; 11(6):e0158010. PubMed ID: 27337093
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein mediated efflux limits the transport of the novel anti-Parkinson's disease candidate drug FLZ across the physiological and PD pathological in vitro BBB models.
Liu Q; Hou J; Chen X; Liu G; Zhang D; Sun H; Zhang J
PLoS One; 2014; 9(7):e102442. PubMed ID: 25036090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
